Shao-Lee Lin - 14 Sep 2022 Form 3 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Director
Signature
/s/ Robert Ho, Attorney-in-Fact
Issuer symbol
THRD
Transactions as of
14 Sep 2022
Net transactions value
$0
Form type
3
Filing time
14 Sep 2022, 18:15:27 UTC
Previous filing
09 Jun 2022
Next filing
27 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding THRD Stock Option (right to buy) 14 Sep 2022 Common Stock 58,056 $0.4500 Direct F1
holding THRD Stock Option (right to buy) 14 Sep 2022 Common Stock 14,958 $0.4500 Direct F2
holding THRD Stock Option (right to buy) 14 Sep 2022 Common Stock 12,739 $0.4500 Direct F3
holding THRD Stock Option (right to buy) 14 Sep 2022 Common Stock 2,866 $1.45 Direct F4
holding THRD Stock Option (right to buy) 14 Sep 2022 Common Stock 6,640 $9.22 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total shares vested on September 14, 2021 and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F2 6.25% vest in quarterly installments over the 4-year period commencing on August 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F3 6.25% vest in quarterly installments over the 4-year period commencing on May 1, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F4 6.25% of the total shares vested on February 24, 2022, and thereafter 6.25% of the total shares underlying the award shall vest in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F5 6.25% vest in quarterly installments over the 4-year period commencing on February 17, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.